The study shows that this drug pair works far better together than either agent alone, offering a realistic and potentially ...

Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study. A new drug strategy that ...

Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.

A new study from Moffitt Cancer Center brings fresh hope to patients battling advanced melanoma who aren’t helped by today’s best treatments. Researchers have found a powerful combination of three ...

Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with certain subtypes of acute myeloid leukemia (AML). Subscribe to our newsletter ...

Combination strategies and switching therapies offer alternatives when monotherapy for alopecia areata is ineffective, addressing limited efficacy and side effects of traditional treatments. JAK ...

Critical Interactions Training Course (Feb 9th - Feb 10th, 2026)" training has been added to ResearchAndMarkets.com's offering. The programme will cover the regulatory strategy to adopt and the ...

Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with certain subtypes of acute myeloid leukemia (AML). The treatment works by using a ...